My pet peeve.
Goldstein
Irwin
I
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000633:toxicity; D000329:Advertising; D000527:Alprostadil / Q000008:administration & dosage / Q000633:toxicity; D001285:Atropine / Q000008:administration & dosage / Q000633:toxicity; D001291:Attitude of Health Personnel; D004359:Drug Therapy, Combination; D004542:Ejaculation / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D010208:Papaverine / Q000008:administration & dosage / Q000633:toxicity; D010276:Parasympatholytics / Q000008:administration & dosage / Q000633:toxicity; D010353:Patient Education as Topic; D010411:Penile Induration / Q000139:chemically induced*; D010413:Penis / Q000098:blood supply; D010646:Phentolamine / Q000008:administration & dosage / Q000633:toxicity; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy* / Q000209:etiology; D014342:Truth Disclosure; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000633:toxicity
D000317:Adrenergic alpha-Antagonists; D010276:Parasympatholytics; D014665:Vasodilator Agents; D001285:Atropine; D010208:Papaverine; D000527:Alprostadil; D010646:Phentolamine